Literature DB >> 14662901

Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease.

Hong-biao Liu1, Kyi Kyi Loo, Karen Palaszynski, Judith Ashouri, Dennis B Lubahn, Rhonda R Voskuhl.   

Abstract

Estrogens are known to influence a variety of autoimmune diseases, but it is not known whether their actions are mediated through classic estrogen receptor alpha (ERalpha). The presence of a functional ER was demonstrated in secondary lymphoid tissues, then ERalpha expression was shown at both the RNA and protein levels in these tissues. Use of ERalpha knockout mice revealed that both the estrogen-induced disease protection and the estrogen-induced reduction in proinflammatory cytokines were dependent upon ERalpha in the prototypic Th1-mediated autoimmune disease experimental autoimmune encephalomyelitis. These findings are central to the design of selective ER modifiers which aim to target biologic responses in specific organ systems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662901     DOI: 10.4049/jimmunol.171.12.6936

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

Review 1.  Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis.

Authors:  Dionne P Robinson; Sabra L Klein
Journal:  Horm Behav       Date:  2012-03-03       Impact factor: 3.587

2.  When the immune system goes on the attack.

Authors:  Vicki Brower
Journal:  EMBO Rep       Date:  2004-08       Impact factor: 8.807

Review 3.  Estrogen and testosterone therapies in multiple sclerosis.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

4.  Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.

Authors:  Noriko Itoh; Roy Kim; Mavis Peng; Emma DiFilippo; Hadley Johnsonbaugh; Allan MacKenzie-Graham; Rhonda R Voskuhl
Journal:  J Neuroimmunol       Date:  2016-10-03       Impact factor: 3.478

5.  Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17β-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD4+ Foxp3+ regulatory T cells.

Authors:  Sheetal Bodhankar; Arthur A Vandenbark; Halina Offner
Journal:  Immunology       Date:  2012-12       Impact factor: 7.397

Review 6.  Pregnancy and multiple sclerosis.

Authors:  Laura Airas; Risto Kaaja
Journal:  Obstet Med       Date:  2012-05-29

7.  GPR30 FORMS AN INTEGRAL PART OF E2-PROTECTIVE PATHWAY IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS.

Authors:  Sheetal Bodhankar; Halina Offner
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2011-12

Review 8.  The importance of studying sex differences in disease: The example of multiple sclerosis.

Authors:  Lisa C Golden; Rhonda Voskuhl
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

9.  Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice.

Authors:  Seema Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  J Neurol Sci       Date:  2009-05-13       Impact factor: 3.181

10.  Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).

Authors:  Stefan M Gold; Manda V Sasidhar; Laurie B Morales; Sienmi Du; Nancy L Sicotte; Seema K Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  Lab Invest       Date:  2009-08-10       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.